Table 3. Treatment outcomes and follow-up completion by case type among those who received outpatient treatment (n = 358).
| Clinical severe infection (N = 202) | Fast breathing only (N = 156) | Total outpatient (N = 358) | ||||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| Treatment completion | ||||||
| Completed treatment per protocol* | 187 | 92.6% | 145 | 92.9% | 332 | 92.7% |
| Received both doses of gentamicin | 193 | 95.0% | NA | NA | NA | NA |
| Received one dose of gentamicin** | 5 | 2.5% | NA | NA | NA | NA |
| Received all 14 doses of dispersible amoxicillin | 178 | 88.1% | 135 | 86.5% | 313 | 87.4% |
| Received 10–13 doses of dispersible amoxicillin | 15 | 7.4% | 10 | 6.4% | 25 | 7.0% |
| Missing information/Lost to follow-up | 9 | 4.5% | 11 | 7.1% | 20 | 5.6% |
| Follow-up at health facility | ||||||
| Completed mandatory day 4 follow-up | 179 | 88.6% | 139 | 89.1% | 318 | 88.8% |
| Completed all follow-up visits per protocol (day 4 and day 8) | 166 | 82.2% | 123 | 78.8% | 289 | 80.7% |
| Follow-up in the community | ||||||
| Received day 3 follow-up | 116 | 57.4% | 96 | 61.5% | 212 | 59.2% |
| Received day 3 and day 6 follow-up per protocol | 114 | 56.4% | 94 | 60.3% | 208 | 58.1% |
| Treatment failure | ||||||
| Declared as clinical treatment failure¥ | 7 | 3.5% | 5 | 2.2% | 12 | 3.4% |
| Lost to follow-up | 7 | 3.5% | 8 | 5.1% | 15 | 4.2% |
*- For clinical severe infection cases: both doses of gentamicin and at least 12 of 14 DT amoxicillin doses; For fast breathing only: at least 12 of 14 DT amoxicillin doses
**Only one child did not receive any doses of gentamicin
¥ -Among 7 clinical severe infection cases: clinical deterioration (5), persistence of same sign(s) on day 4 (2); and (1); Among 5 fast-breathing only cases: persistence of fast breathing on day 8 (3); clinical deterioration (2)